Heart failure & cardiomyopathies

Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?

Eur Heart JPublished Retrospective case series

Authors' conclusion

Combination of AS and TTR-CA may occur in elderly patients particularly those with a low-flow low-gradient AS pattern and carries bad prognosis.

Study context

Population
Patients with severe or moderate aortic stenosis (AS) and transthyretin cardiac amyloidosis (TTR-CA) hospitalised in 6 French cardiology centres over 6 years
Participants
16 patients
Outcome
Characteristics of patients with concomitant AS and TTR-CA
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Age, mean ± SD
79 ± 6 years
Men
81%
NYHA III-IV
Sixty per cent
Carpal tunnel syndrome
31%
AF
56%
NT-proBNP, median (Q1;Q4)
4382 (2425;4730) pg/mL
Elevated cardiac troponin
91%
Severe AS
Eighty-eight per cent (n = 14/16)
Low-gradient AS among severe AS
86% (n = 12)
Interventricular septum thickness, mean ± SD
18 ± 4 mm
LVEF, mean
50 ± 13%
Global LS, mean
−7 ± 4%
TTR-CA histologically proven (rest by biphosphonate scintigraphy)
38%
Wild-type TTR-CA
Eighty-one per cent (n = 13)
Mutated Val122I
one
No genetic test
19% (n = 3)
Surgical valve replacement
63%
Transcatheter valve replacement
13%
Mortality over whole follow-up
44% (n = 7)

Observational data: associations, not effects.

Original publication

Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? Eur Heart J. Published 22 February 2016. doi:10.1093/eurheartj/ehw033

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.